| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2002 | CN1352565A Agent for treating visual cell function disorder |
| 06/05/2002 | CN1352564A Pharmaceutical composition containing elegiline and ginkgo bioloba extract useful for dementia |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352560A Ziprasidone suspension |
| 06/05/2002 | CN1352559A Endoparasiticidal combination |
| 06/05/2002 | CN1352557A Compositions for improivng fertility |
| 06/05/2002 | CN1352556A Therapeutic use of melatonin |
| 06/05/2002 | CN1352555A Use of anticonvulsant derivatives for treating cluster headaches |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1352553A Weight loss after pregnancy |
| 06/05/2002 | CN1352552A Treatment of osteoarthritis |
| 06/05/2002 | CN1352551A Preparations for the application of anti-inflammatory agents |
| 06/05/2002 | CN1352550A Acidic buffered nasal spray |
| 06/05/2002 | CN1352549A Methods and devices for providing prolonged drug therapy |
| 06/05/2002 | CN1352548A Drinkable ibuprofen pharmaceutical suspension |
| 06/05/2002 | CN1352546A Skin whitener |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1352530A Methods for lowering viscosity of glucomannan compositions |
| 06/05/2002 | CN1352529A Process for producing for enhancing immune response in companion animal using a combination of antioxidants |
| 06/05/2002 | CN1351887A Externally applied Chinese medicine decoction |
| 06/05/2002 | CN1351876A Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 06/05/2002 | CN1351871A Compound chlorhexidine cream and its prepairng method |
| 06/05/2002 | CN1351868A Implanted slow-releasing antiseptic preparation and its preparing method |
| 06/05/2002 | CN1351867A Levo-potasisum magnesium asparate infusion injection and preparing method |
| 06/05/2002 | CN1351866A Levo-potassium magnesium aspartate freeze drying powder injection and preparing method |
| 06/05/2002 | CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/05/2002 | CN1085979C Inhibitor for narcotic analgetic dependence/resistance aquisition |
| 06/05/2002 | CN1085947C Powder prepared with colophony, realgar and Huangdan |
| 06/05/2002 | CN1085946C External medicine with anti-infections and recovery function |
| 06/05/2002 | CN1085945C 7-(2-imidazolinylamino) quinoline compounds as alpha -2 adrenocepter agonists |
| 06/05/2002 | CA2364211A1 Combination treatment for depression, anxiety and psychosis |
| 06/05/2002 | CA2330350A1 Therapeutics for chemokine mediated diseases |
| 06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
| 06/04/2002 | USRE37727 Applying at the site of pain, a plaster or gel, comprising from about 2-10% by weight of lidocaine at least in part as the free base in a formulation which provides for intradermal transport of said lidocaine, |
| 06/04/2002 | US6399826 Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| 06/04/2002 | US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 06/04/2002 | US6399799 Monoalkyl quats |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399784 Efficient method for the conversion of nitriles to amidines |
| 06/04/2002 | US6399782 Benzimidazole inhibitors of fructose 1,6-bisphosphatase |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399778 Crystalline solvate |
| 06/04/2002 | US6399777 Salts of arylpiperazinylalkylene heterocycle and a cyclodextrin; water soluble; stability |
| 06/04/2002 | US6399775 Methods for the preparation of polymorphs of doxazosin mesylate |
| 06/04/2002 | US6399774 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/04/2002 | US6399773 Autoimmune disease; transplanting organs |
| 06/04/2002 | US6399766 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
| 06/04/2002 | US6399664 Administration of reactive oxygen intermediates, and more specifically ozone, for modulating the immune and hematopoietic systems of mammals having cancer; especially treating chronic myeloid leukemia |
| 06/04/2002 | US6399662 Method and composition for the treatment of diarrhea and gastrointestinal spasms |
| 06/04/2002 | US6399661 Mixing alkaline powder with powdered creatine until ph is 7-14; powdered additive is added to improve sweetness and taste; finally, further alkaline powder is added to adjust the ph to 7-14. |
| 06/04/2002 | US6399660 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
| 06/04/2002 | US6399658 Composition containing ascorbic acid |
| 06/04/2002 | US6399657 Antiinflammatory agents |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399655 Method for the prophylactic treatment of cataracts |
| 06/04/2002 | US6399654 Biflavanoids and derivatives thereof as antiviral agents |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399652 Method of treating acne vulgaris using avermectin compound |
| 06/04/2002 | US6399651 Method of treating dermatoses using avermectin compound |
| 06/04/2002 | US6399650 Improving the disturbances of the activities of daily living (adl) in a post-stroke patients comprises administering to the patient an effective amount of nefiracetam within the first six months after the stroke |
| 06/04/2002 | US6399649 Compositions and methods for the treatment of chronic lymphocytic leukemia |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399647 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 06/04/2002 | US6399645 Administering indole-3-carbinol and diindolylmethane |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399642 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399640 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 06/04/2002 | US6399639 Administering a 2,4-thiadiazolidinedione compound |
| 06/04/2002 | US6399638 Anticarcinogenic agents; microtubule stabilizing effects |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation |
| 06/04/2002 | US6399634 Benzothiophene compounds, compositions, and methods |
| 06/04/2002 | US6399633 Flavopiridol; low dosage; vascular lesions after ballon or stent |
| 06/04/2002 | US6399632 Administering terfenadine acid metabolite; avoiding cardiac arrhythmias; fexofenadine; carboxyterfenadine |
| 06/04/2002 | US6399630 2-alkoxy-6-halo-9-aminoacridines; blocking anti-apoptotic effect of cpg-odn and cpg-odn-induced secretion of il-6; highly specific; autoimmune disease, arthritis, lupus, inflammatory bowel disease |
| 06/04/2002 | US6399629 Efflux pump inhibitors |
| 06/04/2002 | US6399628 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399622 Evaluating patient for evidence of epstein-barr virus and cytomegalovirus, administering antiviral agents |
| 06/04/2002 | US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
| 06/04/2002 | US6399618 Compositions and methods for modulating sexual activity |
| 06/04/2002 | US6399617 Use |
| 06/04/2002 | US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression |
| 06/04/2002 | US6399613 N,n'-bis(2-hydroxyethyl)pyrazine-2,5- or -2,6-dicarboxamide; diabetes |
| 06/04/2002 | US6399611 2-(4-ethoxycarbonylaminobenzyl)-6-(3,4 -dimethoxyphenyl)-2,3,4, 5-tetrahydropyridazin-3-one or alternately benzyl substituted compounds; phosphodiesterase iv and tumour necrosis factor inhibitors |
| 06/04/2002 | US6399610 Nasal or oral treatment of heart failure; reduced occurance of headaches or palpitation |
| 06/04/2002 | US6399609 Corticotropin releasing factor (crf) antagonists |
| 06/04/2002 | US6399608 Fluoxetine, paroxetine or sertraline with 1,2,4-triazolo (4,3-b)pyridazine derivative; nonsedating anxiolytic modulator of benzodiazepine binding site of gamma amino-butyric acid receptor; central nervous system |
| 06/04/2002 | US6399607 Active over broad ph range; tuberculosis |
| 06/04/2002 | US6399605 Ophthalmic composition comprising a beta -blocker |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 06/04/2002 | US6399600 Antibiotic resistant bateria infections |
| 06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
| 06/04/2002 | US6399595 Steroid sulfatase inhibitors and methods for making and using the same |